Inhibrx: Spinoff Rumors Send Shares Soaring - Stunning Bull Run Can Continue (NASDAQ:INBX)
Inhibrx Biosciences, Inc. stock jumps on Big Pharma spinoff rumors as Phase 2 oncology data and key trial catalysts near. Click for more on INBX stock prospects.
